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Abstract
GhrelincodedbytheGHRLgeneisrelatedtoweight-gain,itsdeactivationpossiblydependingonitshydrolyzationby
butyrylcholinesterase (BChE) encoded by the BCHE gene, an enzyme already associated with the body mass index
(BMI). The aim was to search for relationships between SNPs of the GHRL and BCHE genes with BChE activity, BMI
and obesity in 144 obese and 153 nonobese Euro-Brazilian male blood donors. In the obese individuals, a significant
association with higher BChE activity, in the 72LM+72MM; -116GG genotype class (GHRL and BCHE genes, re-
spectively) was noted. No significant differences were found otherwise, through comparisons between obese and
control individuals, of genotype and allele frequencies in SNPs of the GHRL gene (Arg51Gln and Leu72Met), or
mean BMI between 72LL and 72LM+72MM genotypes. Although there appears to be no direct relationship between
the examined GHRL SNPs and BMI, the association of the 72M SNP with higher BChE activity in obese subjects
probably points to a regulatory mechanism, thereby implying the influence of the GHRL gene on BChE expression,
and a consequential metabolic role in the complex process of fat utilization.
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Obesity is a risk factor in many diseases, such as hy-
pertension, coronary artery disease, type II diabetes,
breast and colon cancer, constituting a current pandemic
disorder.
Ghrelin (Kojima et al., 1999), a peptide related to
food intake, is coded by the GHRL gene (3p25-p26). The
GHS (growth hormone secretagogue) receptor is activated
by acylated ghrelin, although not so with des-acyl ghrelin
(Hosoda et al., 2000). In rodents, it was shown that the ad-
ministration of ghrelin leads to a gain in weight by increas-
ing food intake and reducing fat utilization (Tschöp et al.,
2000). It was further proposed that the decrease in plasma
ghrelin concentration found in obese individuals could rep-
resent a physiological adaptation (Tschöp et al., 2001).
Butyrylcholinesterase(BChE;EC1.1.1.8)plasmaac-
tivity is positively correlated with weight and BMI (body
mass index), in a phenotype (CHE2 C5-) with approxi-
mately 90% population frequency (Chautard-Freire-Maia
et al., 1991; Alcântara et al., 2003), whereas in another
(CHE2 C5+; 10% population frequency), with 20% higher
BChE activity than the former, it is associated with lower
meanweight(Chautard-Freire-Maiaetal.,1991)andlower
meanBMI(Alcântaraetal.,2001).Thisshowsthatindivid-
uals with innate high BChE activity tend to be thinner and
that BChE synthesis is increased in individuals that gain
weight, suggesting that BChE activity is important in en-
ergybalance.DatafromtheBChEknockoutmousethatbe-
came obese and significantly heavier than wild-type
littermates after an 11% fat diet indicate a role for BChE in
fat utilization (Li et al., 2008). Furthermore, SNPs of the
human BCHE gene (3q26.1-q26.2) have been associated to
BMI (Souza et al., 2005; Furtado-Alle et al., 2008).
Considering that ghrelin desacylation may depend on
BChE activity (De Vriese et al., 2004), the search was for
relationships between SNPs of the BCHE and GHRL genes
and the variables BChE activity, BMI and obesity.
The study involved 144 obese (BMI  30 kg/m
2;
mean age 36.6 years) and 153 control (20 kg/m
2  BMI
< 25 kg/m
2; mean age 36.3 years) male blood donors from
Curitiba, south Brazil, ethnically characterized as Euro-
Brazilians on the basis of skin, hair and facial traits. The re-
search was approved by the National's Committee for Eth-
ics in Research (CONEP; registration number 2063).
DNA was extracted by a salting-out method (Lahiri
and Nurnberger Jr, 1991). SNPs were examined for the
GHRL gene (G/A, rs34911341, p.R51Q, 346 nt and C/A, rs
696217, p.L72M, 408 nt) by PCR and Single Strand Con-
formation Analysis. The respective primers designed for
this study were: GHRL15 (TCTCCCAGAGCACAAA
GGAC); GHRL13 (TTCTGCTTGACCTCCATCTTCC);
GHRL25 (GGAGTCGAAGAAGCCACCA); and
GHRL23 (CAGAAGCATAAAACTGCAGAGG). Data
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Short Communicationon genotypes for exons 1 (G/A, rs1126680, -116 nt) and 4
(G/A; rs1803274, p.A539T; 1615 nt) of the BCHE gene,
and BChE plasma activity (Dietz et al., 1972) were ob-
tained from a previous study (Furtado-Alle et al., 2008).
Statistica for Windows (StatSoft, Inc., 1996) was
used for data analysis of: means, frequencies, standard er-
rors, standard deviations, Fisher-exact test, t-test, 
2 test,
linear correlations, and step-wise multiple regression anal-
ysis.
Comparisonsby
2testsshowedthatgenotypeandal-
lele frequencies for Arg51Gln and Leu72Met SNPs of the
GHRL gene did not statistically differ in obese
(51RR = 99.3%, 51RQ = 0.7%; 51Q = 0.35%, and
72LL=88.1%,72LM=11.2%,72MM=0.3%;72M=6.3%
in 141 and 143 subjects, respectively) or control (51RR =
98.7%, 51RQ = 1.3%; 51Q = 0.65%, and 72LL = 87.6%,
72LM = 11.8%, 72MM = 0.6%; 72M = 6.5% in 153 sub-
jects)individuals.Ukkolaetal.(2002)alsodidnotfindany
significant difference in 51Q allele frequency when com-
paring obese with normal individuals, but did show that
there was a variation in samples of different ethnic compo-
sition. In a previous study, no significant difference was
found in 72M frequency between obese and non-obese in-
dividuals (Hinney et al., 2002). Although total 72M fre-
quency (6.4%; N = 296) in the present study was no
different from that obtained for individuals from Utah
(8.3%; p > 0.4), it differs significantly from those found for
Han Chinese (15.6%, p < 0.01), Japanese (18.2%;
p < 0.001), and African individuals (0.8%; p < 0.05), all of
which from the International HapMap Project, thereby
showing an ethnic difference involved in the frequency of
this variant.
Multiple regression step-wise analysis (Table 1) indi-
cated two values for beta, both significantly different from
0, when compared by t-tests: the -116A variant leads to
lower BChE activity whereas the 72M to higher. Although
BChEactivitytendstobehigherinobesethaninnon-obese
individuals (Furtado-Alle et al.. 2008), the 72M variant ap-
pearstocontributetoelevatingthisevenmore.Thissignifi-
cant association is a novelty, and may be considered an
inference, as significance comes close to the 0.05 error
limit. This may be due to a regulatory mechanism by which
the presence of the 72M variant of the GHRL gene induces
BChE synthesis. The -116GG genotype is characterized by
normal BChE activity. However, in the presence of the
72M variant, mean BChE activity is higher (t = 2.18,
p < 0.05) (Table 2). High BChE activity (> 8 KU/L) was
shown in 33% of obese subjects with the 72M variant, but
in only 21% of those homozygous for the 72L SNP. Al-
though the L72M SNP is not located in the coding region
for the mature ghrelin peptide, the 72M allele leads to an
earlier onset of obesity (Ukkola et. al., 2001; Miraglia del
Giudice et al., 2004). According to Ukkola et al. (2002),
variation in preproghrelin peptide could theoretically
changethestructureofoneormoreofthederivedproducts,
this leading to functional consequences.
The association between the -116A variant and lower
BChE activity (Table 1) is already known, and has been re-
ported in obese and nonobese individuals (Furtado-Alle et
al., 2008).
Genotypes72LLand72LM+72MMdidnotdiffersig-
nificantly (t-test) in mean BMI in either control
(23.05  1.29 kg/m
2 and 23.43  0.96 kg/m
2; p > 0.20) or
obese (32.95  3.29 kg/m
2 and 32.90  2.7 kg/m
2; p > 0.95)
individuals.NodifferenceinmeanBMIwasfoundinobese
individuals, when genotypes 72LL and 72LM+72MM,
identical for genotypes -116GG;539AA,- 116GG;539AT or
-116GA;539ATofexons1and4oftheBCHEgene,respec-
tively, were compared. Obese individuals with and without
the72Mvarianthavealreadybeencompared(Ukkolaetal.,
2001), with no difference found in mean BMI.
Although the examined GHRL SNPs do not appear to
be directly related to BMI, the association of the 72M SNP
with higher BChE activity in obese subjects although re-
quiring further study, points to a regulatory mechanism,
thus indicating the influence of the GHRL gene on BChE
expression and, consequently, its possible role in the com-
plex process of fat utilization.
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Table 1 - Results from step-wise multiple regression analysis that consid-
eredbutyrylcholinesteraseactivityasdependentvariableinobeseindivid-
uals (N = 130).
Independent variables
a Beta
b  S.E. t
BCHE gene
c -0.21  0.09 2.51 (p < 0.02)
GHRL gene
d 0.18  0.09 2.09 (p < 0.05)
F = 5.52 (p < 0.01); r
2 = 0.08
aNonsignificant independent variables: age, body-mass index, A539T of
the BCHE gene.
bRegression coefficients for the standardized variables to
amean0andSD1,allowingforcomparisonoftherelativecontributionof
each independent variable in predicting the dependent variable, also com-
parable across variables.
c(-116GG =1 ,-116GA = 2).
d(72LL =1 ,
72LM+72MM = 2).
Table 2 - Butyrylcholinesterase mean activity in 130 obese individuals,
grouped by genotypes of GHRL (Leu72Met) and BCHE (G-116A) genes.
Genotypes n Mean BChE activity (KU/L)  S.D.
72LM+72MM; -116GG
a 13 8.42  4.08
72LL; -116GG
a 95 6.55  2.80
72LM+72MM; -116GA 2 5.22  1.89
72LL; -116GA 20 5.04  2.11
at-test = 2.18; p < 0.05 when comparing 72LM+72MM; -116GG with
72LL; -116GG.References
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